Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
Clinical Chemistry
|
August 23, 2008
Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study
Alexander Kohlmann, Elisabeth Haschke-Becher, Barbara Wimmer, et al.
The Journal of Molecular Diagnostics : JMD
|
July 27, 2016
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods
Chih-Jian Lih, Han Si, Biswajit Das, et al.
NPJ Precision Oncology
|
September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
Erin R Bonner, Robin Harrington, Augustine Eze, et al.
BMC Medicine
|
November 16, 2013
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Nature
|
October 18, 2013
Criteria for the use of omics-based predictors in clinical trials
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K
Carolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology
|
February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E
Neal Akhave, Zihe Song, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)
Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
Clinical Chemistry
|
August 23, 2008
Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study
Alexander Kohlmann, Elisabeth Haschke-Becher, Barbara Wimmer, et al.
The Journal of Molecular Diagnostics : JMD
|
July 27, 2016
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods
Chih-Jian Lih, Han Si, Biswajit Das, et al.
NPJ Precision Oncology
|
September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
Erin R Bonner, Robin Harrington, Augustine Eze, et al.
BMC Medicine
|
November 16, 2013
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
JCO Precision Oncology
|
July 12, 2021
Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health
P Mickey Williams, Thomas Forbes, Steven P Lund, et al.
Nature
|
October 18, 2013
Criteria for the use of omics-based predictors in clinical trials
Lisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K
Carolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology
|
February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E
Neal Akhave, Zihe Song, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2025
Concordance between tumor tissue and plasma DNA genotyping in the NCI-MATCH trial (EAY131)
Mohamed A Gouda, Filip Janku, Ying Yuan, et al.
Page
of 9